Seres Therapeutics, Inc. (MCRB) Net Income by Year
Seres Therapeutics, Inc. reported $5.7M in net income in fiscal year 2025. This represents an increase of 4088.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Seres Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MCRB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
MCRB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Seres Therapeutics, Inc. financials
Frequently Asked Questions
What was Seres Therapeutics, Inc.'s net income in fiscal year 2025?
Seres Therapeutics, Inc. reported $5.7M in net income in fiscal year 2025.
How fast is Seres Therapeutics, Inc.'s net income growing?
Seres Therapeutics, Inc. (MCRB) net income rose by 4088.2% year over year, from $136K to $5.7M in fiscal year 2025.
How has Seres Therapeutics, Inc.'s net income changed over the years?
Across the 13 fiscal years this page covers, Seres Therapeutics, Inc. (MCRB) net income went from -$6.1M in fiscal year 2013 to $5.7M in fiscal year 2025.
What was Seres Therapeutics, Inc.'s net income in the most recent quarter?
Seres Therapeutics, Inc. (MCRB) reported $4.6M in net income in Q2 2026. This represents an increase of 123.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Seres Therapeutics, Inc. (MCRB) reported on that line in every period on record.